Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401232 · ClinicalTrials.gov registry record · NA
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 955
- Enrollment target
NCT00401232: Completed NA study, sponsored by Pfizer.
NCT00401232 is a NA study that has completed, run by Pfizer. The registered enrollment target is 955 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00401232, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 955 participants
- Enrollment target
Study Summary
This is a study to collect blood from volunteers to assist in assay development.
Interventions
- PROCEDURE Blood Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 955 participants |
| Start Date | 2006-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT00401232 record still lists
NCT00401232 is an interventional study that assigns participants to a tested intervention. The registered 955 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 1 intervention - of which Blood Collection is the first listed.
NCT00401232 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00401232 about?
NCT00401232 is a clinical study titled "Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development". This is a study to collect blood from volunteers to assist in assay development.
What is the current status of trial NCT00401232?
This trial is currently completed. It is a NA study. The enrollment target is 955 participants. The study started on 2006-08. Estimated completion is 2017-12.
What interventions are being tested in trial NCT00401232?
The interventions under investigation include: Blood Collection (PROCEDURE).
Who is sponsoring clinical trial NCT00401232?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00401232's enrollment target sits among peer trials
955 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06225596 · 956 participants · Phase 2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- NCT06259669 · 958 participants
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- NCT04375033 · 952 participants · Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia